Advancing a new age of biologics
ADMA Biologics (admabiologics.com) earns a Brand Analyzer score of 75 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Manufacturing brands. Among 4745 Healthcare brands analyzed, ADMA Biologics ranks in the 53rd percentile (category average 74, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 85/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 80/100, AI Discoverability 71/100, Brand Authority 21/100.
ADMA Biologics is a specialty biopharmaceutical company headquartered in Ramsey, United States, focused on developing, manufacturing, and marketing FDA-approved immune globulin products. The company serves patients with primary immunodeficiency and infectious diseases, as well as healthcare providers and biopharmaceutical partners. ADMA Biologics utilizes a vertically integrated, end-to-end manufacturing process and proprietary microneutralization assay technology to ensure product quality, and it also offers contract manufacturing services for plasma-derived biologics.
| Brand Name | ADMA Biologics |
|---|---|
| Domain | admabiologics.com |
| Industry | Healthcare, Manufacturing |
| Headquarters | Ramsey |
| Main Competitors | Grifols (89/100), CSL Behring (87/100), Takeda (87/100), Octapharma (88/100), Kedrion Biopharma (78/100), Biotest |
Moz Domain Authority 40/100 vs category average 38 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,090,343 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "ADMA Biologics | FDA-Approved Immune Globulin Products" (Meta description: 7 words. OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, og:image, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, HubSpot.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
ADMA Biologics scores 36/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
ADMA Biologics has a weak AI-visibility profile at 36/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,090,343 (Tranco) and a Moz Domain Authority of 40/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify ADMA Biologics from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is ADMA Biologics?", Claude could identify the brand as of August 2026. ADMA Biologics is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment and prevention of infectious diseases, particularly in immunocompromised patients. Best known for Its plasma-derived immunoglobulin products like ASCENIV, Bivigam, and Nabi-HB for immune deficiencies and infectious disease prevention.
When asked "Best brands similar to ADMA Biologics?", Claude would recommend ADMA Biologics as of August 2026. It's a legitimate and notable player in the plasma-derived therapeutics space, especially for immunoglobulin products used in primary immunodeficiency treatment.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
ADMA Biologics's main competitors include Grifols (89/100), CSL Behring (87/100), Takeda (87/100), Octapharma (88/100), Kedrion Biopharma (78/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
ADMA Biologics and Grifols are competitors in Healthcare. Brand Analyzer scores ADMA Biologics at 75/100 and Grifols at 89/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to ADMA Biologics include Grifols (89/100), CSL Behring (87/100), Takeda (87/100), Octapharma (88/100), Kedrion Biopharma (78/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
ADMA Biologics offers FDA-approved plasma-derived immune globulin products designed to treat patients with primary immunodeficiency and infectious diseases. It also provides contract manufacturing services for biopharmaceutical partners seeking plasma-derived biologic production using its vertically integrated manufacturing capabilities.
Sources: ADMA Biologics official site
ADMA Biologics is a specialty biopharmaceutical company based in Ramsey, United States, that develops, manufactures, and markets FDA-approved immune globulin products for patients with immune deficiencies and infectious diseases.
Sources: ADMA Biologics official site
ADMA Biologics has limited AI-search visibility, scoring 36/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 43, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: ADMA Biologics official site
ADMA Biologics is headquartered in Ramsey. ADMA Biologics operates in the Healthcare category.
Sources: Wikidata
ADMA Biologics develops, manufactures, and markets FDA-approved plasma-derived immune globulin products. It uses a vertically integrated, end-to-end manufacturing process supported by proprietary microneutralization assay technology to measure antibody titers and ensure product quality. The company also provides contract manufacturing services for other biopharmaceutical partners producing plasma-derived biologics.
Sources: ADMA Biologics official site
ADMA Biologics scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: ADMA Biologics official site
ADMA Biologics is known for its FDA-approved immune globulin products used to treat primary immunodeficiency and infectious diseases, as well as for its vertically integrated manufacturing process and proprietary microneutralization assay technology used to ensure precise antibody titer measurement.
Sources: ADMA Biologics official site
ADMA Biologics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: ADMA Biologics official site
ADMA Biologics' products and services are used by healthcare providers who treat patients with primary immunodeficiency and infectious diseases, by patients receiving immune globulin therapies, and by biopharmaceutical partners that use ADMA's contract manufacturing capabilities for plasma-derived biologics.
Sources: ADMA Biologics official site
Ranked closest to ADMA Biologics: Johnson & Johnson Innovative Medicine (75/100), Accuity (75/100), AIHM (Academy of Integrative Health & Medicine) (75/100), Aline (75/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).